The Evidence Gap - Costly Cancer Drug Offers Hope, but also a Dilemma
The Evidence Gap - Costly Cancer Drug Offers Hope, but also a Dilemma (New York Times).
Arzneimittel - Brustkrebs - Kosten-Nutzen - Off-Label-Use - Onkologie - Statistik - Zusatzentgelte - URL